Chemring Group PLC (LON:CHG)
London · Delayed Price · Currency is GBP · Price in GBX 525.00
-6.00 (-1.13%)
Jun 12, 2026, 4:35 PM GMT
Chemring Group Income Statement
Financials in millions GBP. Fiscal year is November - October.
Millions GBP. Fiscal year is Nov - Oct.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 30, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 |
| 512 | 497.5 | 488.3 | 472.6 | 401 | 393.3 | |
Revenue Growth (YoY) | 4.98% | 1.88% | 3.32% | 17.85% | 1.96% | -2.29% |
Cost of Revenue | 164.4 | 164.4 | 159.7 | 147.2 | - | - |
Gross Profit | 347.6 | 333.1 | 328.6 | 325.4 | 401 | 393.3 |
Selling, General & Admin | 203.3 | 203.3 | 189.1 | 177.2 | 0.1 | 0.1 |
Research & Development | 14.2 | 14.2 | 14 | 10.1 | - | - |
Amortization of Goodwill & Intangibles | 2.9 | 2.9 | 2.3 | 3 | - | - |
Other Operating Expenses | 32.7 | 12.1 | 27.3 | 43.7 | 343.1 | 336.7 |
Operating Expenses | 282.4 | 260.4 | 259 | 252.6 | 349.6 | 342.1 |
Operating Income | 65.2 | 72.7 | 69.6 | 72.8 | 51.4 | 51.2 |
Interest Expense | -5.6 | -5.7 | -4.8 | -0.7 | -1.4 | -1.5 |
Currency Exchange Gain (Loss) | -0.8 | -0.8 | -0.3 | -2.7 | -2 | 0.8 |
Other Non Operating Income (Expenses) | - | - | - | 0.1 | - | - |
EBT Excluding Unusual Items | 58.8 | 66.2 | 64.5 | 69.5 | 48 | 50.5 |
Merger & Restructuring Charges | -5.4 | -5.5 | -3.4 | -3.7 | -2 | -1.6 |
Gain (Loss) on Sale of Assets | -0.1 | -0.1 | -1.7 | - | 1.9 | -0.1 |
Asset Writedown | - | - | - | -18.5 | - | - |
Legal Settlements | 0.2 | 0.2 | 3.1 | -3.2 | - | - |
Other Unusual Items | 7.1 | 6.9 | -10.7 | - | - | - |
Pretax Income | 60.6 | 67.7 | 51.8 | 44.1 | 47.9 | 48.8 |
Income Tax Expense | 13.3 | 14.4 | 10.3 | 6.4 | 3.5 | 7.3 |
Earnings From Continuing Operations | 47.3 | 53.3 | 41.5 | 37.7 | 44.4 | 41.5 |
Earnings From Discontinued Operations | -13.4 | -5.1 | -2 | -32.3 | 3 | - |
Net Income | 33.9 | 48.2 | 39.5 | 5.4 | 47.4 | 41.5 |
Net Income to Common | 33.9 | 48.2 | 39.5 | 5.4 | 47.4 | 41.5 |
Net Income Growth | -22.07% | 22.02% | 631.48% | -88.61% | 14.22% | 19.60% |
Shares Outstanding (Basic) | 271 | 271 | 273 | 282 | 281 | 282 |
Shares Outstanding (Diluted) | 277 | 276 | 279 | 289 | 288 | 288 |
Shares Change (YoY) | -0.03% | -1.10% | -3.34% | 0.19% | 0.08% | -0.15% |
EPS (Basic) | 0.13 | 0.18 | 0.14 | 0.02 | 0.17 | 0.15 |
EPS (Diluted) | 0.12 | 0.17 | 0.14 | 0.02 | 0.16 | 0.14 |
EPS Growth | -22.41% | 23.05% | 640.65% | -88.35% | 14.17% | 20.00% |
Free Cash Flow | -10.5 | -2.3 | 16.2 | 33.2 | 49 | 47.7 |
Free Cash Flow Per Share | -0.04 | -0.01 | 0.06 | 0.12 | 0.17 | 0.17 |
Dividend Per Share | 0.081 | 0.080 | 0.078 | 0.069 | 0.057 | 0.048 |
Dividend Growth | 2.53% | 2.56% | 13.04% | 21.05% | 18.75% | 23.08% |
Gross Margin | 67.89% | 66.95% | 67.30% | 68.85% | 100.00% | 100.00% |
Operating Margin | 12.73% | 14.61% | 14.25% | 15.40% | 12.82% | 13.02% |
Profit Margin | 6.62% | 9.69% | 8.09% | 1.14% | 11.82% | 10.55% |
Free Cash Flow Margin | -2.05% | -0.46% | 3.32% | 7.03% | 12.22% | 12.13% |
EBITDA | 88.5 | 94.9 | 90.4 | 92.7 | 71.9 | 74.3 |
EBITDA Margin | 17.29% | 19.07% | 18.51% | 19.61% | 17.93% | 18.89% |
D&A For EBITDA | 23.3 | 22.2 | 20.8 | 19.9 | 20.5 | 23.1 |
EBIT | 65.2 | 72.7 | 69.6 | 72.8 | 51.4 | 51.2 |
EBIT Margin | 12.73% | 14.61% | 14.25% | 15.40% | 12.82% | 13.02% |
Effective Tax Rate | 21.95% | 21.27% | 19.88% | 14.51% | 7.31% | 14.96% |